568 related articles for article (PubMed ID: 21994621)
1. Tropism-modification strategies for targeted gene delivery using adenoviral vectors.
Coughlan L; Alba R; Parker AL; Bradshaw AC; McNeish IA; Nicklin SA; Baker AH
Viruses; 2010 Oct; 2(10):2290-2355. PubMed ID: 21994621
[TBL] [Abstract][Full Text] [Related]
2. Tropism and transduction of oncolytic adenovirus 5 vectors in cancer therapy: Focus on fiber chimerism and mosaicism, hexon and pIX.
Stepanenko AA; Chekhonin VP
Virus Res; 2018 Sep; 257():40-51. PubMed ID: 30125593
[TBL] [Abstract][Full Text] [Related]
3. Role of the putative heparan sulfate glycosaminoglycan-binding site of the adenovirus type 5 fiber shaft on liver detargeting and knob-mediated retargeting.
Bayo-Puxan N; Cascallo M; Gros A; Huch M; Fillat C; Alemany R
J Gen Virol; 2006 Sep; 87(Pt 9):2487-2495. PubMed ID: 16894186
[TBL] [Abstract][Full Text] [Related]
4. Manipulating adenovirus hexon hypervariable loops dictates immune neutralisation and coagulation factor X-dependent cell interaction in vitro and in vivo.
Ma J; Duffy MR; Deng L; Dakin RS; Uil T; Custers J; Kelly SM; McVey JH; Nicklin SA; Baker AH
PLoS Pathog; 2015 Feb; 11(2):e1004673. PubMed ID: 25658827
[TBL] [Abstract][Full Text] [Related]
5. Hepatocyte Heparan Sulfate Is Required for Adeno-Associated Virus 2 but Dispensable for Adenovirus 5 Liver Transduction In Vivo.
Zaiss AK; Foley EM; Lawrence R; Schneider LS; Hoveida H; Secrest P; Catapang AB; Yamaguchi Y; Alemany R; Shayakhmetov DM; Esko JD; Herschman HR
J Virol; 2016 Jan; 90(1):412-20. PubMed ID: 26491162
[TBL] [Abstract][Full Text] [Related]
6. Influence of fiber detargeting on adenovirus-mediated innate and adaptive immune activation.
Schoggins JW; Nociari M; Philpott N; Falck-Pedersen E
J Virol; 2005 Sep; 79(18):11627-37. PubMed ID: 16140740
[TBL] [Abstract][Full Text] [Related]
7. Simultaneous CAR- and alpha V integrin-binding ablation fails to reduce Ad5 liver tropism.
Martin K; Brie A; Saulnier P; Perricaudet M; Yeh P; Vigne E
Mol Ther; 2003 Sep; 8(3):485-94. PubMed ID: 12946322
[TBL] [Abstract][Full Text] [Related]
8. Retargeting of gene expression using endothelium specific hexon modified adenoviral vector.
Kaliberov SA; Kaliberova LN; Hong Lu Z; Preuss MA; Barnes JA; Stockard CR; Grizzle WE; Arbeit JM; Curiel DT
Virology; 2013 Dec; 447(1-2):312-25. PubMed ID: 24210128
[TBL] [Abstract][Full Text] [Related]
9. Substitution of adenovirus serotype 3 hexon onto a serotype 5 oncolytic adenovirus reduces factor X binding, decreases liver tropism, and improves antitumor efficacy.
Short JJ; Rivera AA; Wu H; Walter MR; Yamamoto M; Mathis JM; Curiel DT
Mol Cancer Ther; 2010 Sep; 9(9):2536-44. PubMed ID: 20736345
[TBL] [Abstract][Full Text] [Related]
10. Mutation of the fiber shaft heparan sulphate binding site of a 5/3 chimeric adenovirus reduces liver tropism.
Koski A; Karli E; Kipar A; Escutenaire S; Kanerva A; Hemminki A
PLoS One; 2013; 8(4):e60032. PubMed ID: 23585829
[TBL] [Abstract][Full Text] [Related]
11. Requirements for receptor engagement during infection by adenovirus complexed with blood coagulation factor X.
Bradshaw AC; Parker AL; Duffy MR; Coughlan L; van Rooijen N; Kähäri VM; Nicklin SA; Baker AH
PLoS Pathog; 2010 Oct; 6(10):e1001142. PubMed ID: 20949078
[TBL] [Abstract][Full Text] [Related]
12. Reduction of natural adenovirus tropism to mouse liver by fiber-shaft exchange in combination with both CAR- and alphav integrin-binding ablation.
Koizumi N; Mizuguchi H; Sakurai F; Yamaguchi T; Watanabe Y; Hayakawa T
J Virol; 2003 Dec; 77(24):13062-72. PubMed ID: 14645563
[TBL] [Abstract][Full Text] [Related]
13. Capsid modification strategies for detargeting adenoviral vectors.
Parker AL; Bradshaw AC; Alba R; Nicklin SA; Baker AH
Methods Mol Biol; 2014; 1089():45-59. PubMed ID: 24132476
[TBL] [Abstract][Full Text] [Related]
14. Gene transduction and cell entry pathway of fiber-modified adenovirus type 5 vectors carrying novel endocytic peptide ligands selected on human tracheal glandular cells.
Gaden F; Franqueville L; Magnusson MK; Hong SS; Merten MD; Lindholm L; Boulanger P
J Virol; 2004 Jul; 78(13):7227-47. PubMed ID: 15194799
[TBL] [Abstract][Full Text] [Related]
15. Engineering of adenovirus vectors containing heterologous peptide sequences in the C terminus of capsid protein IX.
Dmitriev IP; Kashentseva EA; Curiel DT
J Virol; 2002 Jul; 76(14):6893-9. PubMed ID: 12072490
[TBL] [Abstract][Full Text] [Related]
16. Biodistribution and retargeting of FX-binding ablated adenovirus serotype 5 vectors.
Alba R; Bradshaw AC; Coughlan L; Denby L; McDonald RA; Waddington SN; Buckley SM; Greig JA; Parker AL; Miller AM; Wang H; Lieber A; van Rooijen N; McVey JH; Nicklin SA; Baker AH
Blood; 2010 Oct; 116(15):2656-64. PubMed ID: 20610817
[TBL] [Abstract][Full Text] [Related]
17. Receptor interactions involved in adenoviral-mediated gene delivery after systemic administration in non-human primates.
Smith TA; Idamakanti N; Marshall-Neff J; Rollence ML; Wright P; Kaloss M; King L; Mech C; Dinges L; Iverson WO; Sherer AD; Markovits JE; Lyons RM; Kaleko M; Stevenson SC
Hum Gene Ther; 2003 Nov; 14(17):1595-604. PubMed ID: 14633402
[TBL] [Abstract][Full Text] [Related]
18. Adenovirus 5 fibers mutated at the putative HSPG-binding site show restricted retargeting with targeting peptides in the HI loop.
Kritz AB; Nicol CG; Dishart KL; Nelson R; Holbeck S; Von Seggern DJ; Work LM; McVey JH; Nicklin SA; Baker AH
Mol Ther; 2007 Apr; 15(4):741-9. PubMed ID: 17245351
[TBL] [Abstract][Full Text] [Related]
19. Cell entry and trafficking of human adenovirus bound to blood factor X is determined by the fiber serotype and not hexon:heparan sulfate interaction.
Corjon S; Gonzalez G; Henning P; Grichine A; Lindholm L; Boulanger P; Fender P; Hong SS
PLoS One; 2011; 6(5):e18205. PubMed ID: 21637339
[TBL] [Abstract][Full Text] [Related]
20. Retargeting of adenoviral infection to melanoma: combining genetic ablation of native tropism with a recombinant bispecific single-chain diabody (scDb) adapter that binds to fiber knob and HMWMAA.
Nettelbeck DM; Rivera AA; Kupsch J; Dieckmann D; Douglas JT; Kontermann RE; Alemany R; Curiel DT
Int J Cancer; 2004 Jan; 108(1):136-45. PubMed ID: 14618628
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
